Gilead says drug helped moderately ill coronavirus patients

A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday but said full results would soon be published in a medical journal. Remdesivir is the only treatment that�s been shown in a rigorous experiment to help fight the coronavirus. A large study led by the National...